Foundayo (orforglipron)

Foundayo (orforglipron), an FDA-approved, once-daily oral GLP-1 receptor agonist pill developed by Eli Lilly.

Please note that it is not approved for patients under the age of 18 and does not require refrigeration. Additionally, the pharmacy only allows one dose per prescription.

Initial Dose: All patients must start at 0.8 mg ($149/month)

Please let me know if you would like to proceed with a 30, 60, or 90-day supply of the 0.8 mg starting dose.